63,461 Shares in DaVita Inc. $DVA Purchased by PBU The Pension Fund of Early Childhood & Youth Educators

PBU The Pension Fund of Early Childhood & Youth Educators purchased a new position in DaVita Inc. (NYSE:DVA) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 63,461 shares of the company’s stock, valued at approximately $7,210,000. PBU The Pension Fund of Early Childhood & Youth Educators owned approximately 0.09% of DaVita at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Elevation Wealth Partners LLC boosted its stake in DaVita by 147.3% in the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock worth $31,000 after purchasing an additional 165 shares in the last quarter. Canada Pension Plan Investment Board bought a new position in DaVita in the 2nd quarter worth about $43,000. iSAM Funds UK Ltd bought a new position in DaVita in the 3rd quarter worth about $46,000. Stance Capital LLC bought a new position in DaVita in the 3rd quarter worth about $47,000. Finally, Fideuram Asset Management Ireland dac bought a new position in DaVita in the 4th quarter worth about $49,000. Institutional investors own 90.12% of the company’s stock.

Insider Buying and Selling at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the transaction, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. This represents a 27.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by company insiders.

DaVita Stock Performance

DVA opened at $192.28 on Friday. The stock has a market capitalization of $12.34 billion, a P/E ratio of 17.84, a P/E/G ratio of 0.63 and a beta of 0.91. The company’s 50-day simple moving average is $171.47 and its two-hundred day simple moving average is $143.18. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $202.69.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. During the same quarter in the prior year, the business earned $2.00 EPS. The business’s quarterly revenue was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts forecast that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. UBS Group upped their price target on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. TD Cowen upped their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. Finally, Barclays upped their target price on shares of DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $199.17.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.